| Literature DB >> 24717984 |
Imelda Bates1, Alan Boyd2, Garry Aslanyan2, Donald C Cole2.
Abstract
Strengthening research capacity in low- and middle-income countries is one of the most effective ways of advancing their health and development but the complexity and heterogeneity of health research capacity strengthening (RCS) initiatives means it is difficult to evaluate their effectiveness. Our study aimed to enhance understanding about these difficulties and to make recommendations about how to make health RCS evaluations more effective. Through discussions and surveys of health RCS funders, including the ESSENCE on Health Research initiative, we identified themes that were important to health RCS funders and used these to guide a systematic analysis of their evaluation reports. Eighteen reports, produced between 2000 and 2013, representing 12 evaluations, were purposefully selected from 54 reports provided by the funders to provide maximum variety. Text from the reports was extracted independently by two authors against a pre-designed framework. Information about the health RCS approaches, tensions and suggested solutions was re-constructed into a narrative. Throughout the process contacts in the health RCS funder agencies were involved in helping us to validate and interpret our results. The focus of the health RCS evaluations ranged from individuals and institutions to national, regional and global levels. Our analysis identified tensions around how much stakeholders should participate in an evaluation, the appropriate balance between measuring and learning and between a focus on short-term processes vs longer-term impact and sustainability. Suggested solutions to these tensions included early and ongoing stakeholder engagement in planning and evaluating health RCS, modelling of impact pathways and rapid assimilation of lessons learned for continuous improvement of decision making and programming. The use of developmental approaches could improve health RCS evaluations by addressing common tensions and promoting sustainability. Sharing learning about how to do robust and useful health RCS evaluations should happen alongside, not after, health RCS efforts. Published by Oxford University Press in association with The London School of Hygiene and Tropical MedicineEntities:
Keywords: Low- and middle-income countries; capacity strengthening; health; research
Mesh:
Year: 2014 PMID: 24717984 PMCID: PMC4353897 DOI: 10.1093/heapol/czu016
Source DB: PubMed Journal: Health Policy Plan ISSN: 0268-1080 Impact factor: 3.344
Characteristics of funders’ evaluations of health RCS
| Evaluations | Health RCS characteristics | Relation of evaluator to funder | Evaluation characteristics | ||
|---|---|---|---|---|---|
| Funder | Project, programme(s), organization | Period (duration) covered by the evaluation | Timing | Main approaches/methods | |
| Lead author of report (year of publication) | |||||
| ACU-CSC | CS programme—with streams, health sector | 1960+ (48 years) | Funder staff | Periodic review | Analysis of existing award data, alumni evaluation survey, 15 case studies and five telephone interviews of selected scholarship recipients. Impact assessment. |
| Carnegie | RCS initiative with networks | 2008–10 (2 years) | Contract evaluation organization | Mid-term | Desk review or initiative and network documents, interviews and focus groups with stakeholders (key staff and students within each network). |
| Danida Health Research for Action (HERA) ( | HR programmes of which health RCS a part | 1997–2006 (10 years) | Contracted evaluation organization | Periodic review | Components were: (a) country reports with visits; (b) desk study review of projects; (c) institutional questionnaires for Danish research groups; (d) ‘internal’ (Danish organizations) individual staff questionnaires; (e) ‘external’ (non-Danish other High Income Country funder) questionnaires and interviews; (f) literature review of publications supported; (g) evaluation document analysis and (h) health-related project database analysis. |
| DfID | Project-HR council | 2008–10 (2 years) | External programme evaluation team | Mid-term review | Desk review of organizational, programme and project documentation; site visit with interviews of stakeholders, beneficiaries, non-beneficiaries, funders and secretariat; in-depth case studies of selected grantees and their institutions and evaluation of the grants selection process. |
| EDCTP | HR partnership | 2007–09 (2 years) | Independent external panel | Periodic review | Documentation analysis, meetings-discussions and interviews with organizational representatives, questionnaire survey of researchers, site visit, conference attendance and country case study. |
| IDRC | HR programme with projects | Roughly 2001–08 (7 years) | Contracted evaluation team | Special review | Conducted a gender audit at three levels—institutional, programmatic and project (review of 15 projects)—through documentation review; search of guidelines and strategies of other organizations working on policy, health and gender issues; review of a previous internal gender survey; gender questionnaire to assess capacity development needs and individual interviews with funder staff. |
| NIH-FIC (1) | Health RCS Programme | 1992–2003 (11 years) | Contract evaluators | Periodic review | Outcome evaluation using NIH-FIC evaluation framework and Fogarty International Research Collaboration Award logic model. Administrative data collection and review, interviews with programme stakeholders, census surveys of the US principal investigators and international research collaborators, bibliometric analysis of publications and site visits. |
| NIH-FIC (2) | Health RCS Programme | 2002–08 (6 years) | Contract evaluation team | Mid-term review | Programme implementation and preliminary outcomes. Data collection methods included two online surveys (Global Research Initiative Program (GRIP) awardees, unsuccessful applicants with scored applications). Supplementary data from administrative sources and databases, MEDLINE, and from interviews with US-based mentors, FIC staff members and programme partners. |
| NWO/WOTRO | Health RCS and HR programmes | 2005–08 (4 years) | [1a] Committee of three experts and two secretariat members | Mid-term review | [1a]Background document review, discussions with programme co-ordinators, site visits with interviews, formulate recommendations and discuss with Programme Committee |
| [1b] Contract evaluators | [1b] Not specified but included: programme document review, programme logic construction, projects’ progress reports analysis and stakeholder interviews. | ||||
| SIDA | Linked health RCS project funding (three routes) | 1999–2005 (6 years) | Contract evaluators | Mid-term for re-formulation | Emailed questionnaires to institutions, individuals and graduates. Interviews during site visits and evaluation seminar at main site. |
| TDR-WHO | Organization’s entire set of health RCS programmes | 2000–08 (9 years) | Contracted institute evaluation team | Periodic review | Questionnaires (individuals, research groups and institutions), selected in-depth interviews, institutional site visits with stakeholder semi-structured interviews. |
| Wellcome Trust | Health RCS Project—Consortium | 2009–11 (2 years) | Contract evaluation organization | Mid-term (second annual) | Real-time, monitoring and evaluation with mutually agreed framework of qualitative and quantitative indicators. Analysis in the light of all consortia within the programme of which this project is a part. |
CS, capacity strengthening; HR, health research; ACU-CSC, Association of Commonwealth Universities-Commonwealth Scholarship Commission; Carnegie, Carnegie Corporation of New York through Science Initiative Group; Danida, Development co-operation activity, Ministry of Foreign Affairs (Denmark); DfID, Department for International Development (UK); EDCTP, European and Developing Countries Clinical Trials Partnership; IDRC, International Development Research Centre (Canada); NIH-FIC, National Institutes of Health-Fogarty International Center (USA); NWO/WOTRO, Science for Global Development, Netherlands Organization for Scientific Research; SIDA, Swedish International Development Agency; TDR-WHO, Tropical Disease Research-World Health Organization.
Recommendations to avoid tensions in health RCS evaluations synthesized from evaluation reports and categorized by theme
| Funders and recipients (and evaluators) will design a better project, learn more, have more ownership of recommendations and be more likely to implement them if they are involved closely in developing and formulating the CS evaluations. |
| A comprehensive and planned approach is required to demonstrate the value that health RCS brings. Impact and value for money should be considered throughout a project, from design of initiatives through to influence at systems, institutional and political levels. |
| Lessons learned about health RCS should be systematically documented and shared within and between funders and between projects, and used to inform organizational decision making and programme planning. |
| Sustainable capacity development has a long time frame and needs long- and short-term monitoring and evaluation (M&E). M&E activities should be beneficial, feasible (e.g. adequate resources), avoid unnecessary administrative burden and be used for learning. Research timescales need to be flexible if effective CS is to be achieved alongside a research project. |